Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval symbols : NVAX save search
Novavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore
Published: 2023-10-18 (Crawled : 13:30) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -0.78%
H: 2.5%
C: 1.09%
covid-19 vaccine prototype approval
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand for Adolescents Aged 12 Through 17
Published: 2022-08-18 (Crawled : 14:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: -6.47%
covid-19 vaccine granted approval
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a First and Second Booster for Adults
Published: 2022-08-17 (Crawled : 13:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -1.82%
H: 1.31%
C: -6.48%
covid-19 vaccine granted approval
Novavax Announces Expanded Approval of Nuvaxovid™ COVID-19 Vaccine for Adolescents Aged 12 through 17 in Japan
Published: 2022-07-26 (Crawled : 12:20) - prnewswire.com
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -0.2%
H: 6.0%
C: 2.08%
covid-19 japan vaccine approval
Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster Immunization in Japan
Published: 2022-04-19 (Crawled : 12:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -9.57%
H: 4.12%
C: 2.61%
covid-19 japan vaccine approval
New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine
Published: 2022-02-03 (Crawled : 23:00) - prnewswire.com
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -0.2%
H: 3.78%
C: 1.16%
covid-19 approval covid vaccine grant granted
Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine
Published: 2021-12-16 (Crawled : 05:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 1.18%
H: 0.0%
C: 0.0%
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 5.55%
H: 0.0%
C: 0.0%
covid-19 new drug application drug approval covid vaccine submission
Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373
Published: 2021-11-15 (Crawled : 14:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 1.31%
H: 0.0%
C: 0.0%
application license approval submission nvx-cov2373
Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand
Published: 2021-11-03 (Crawled : 14:00) - prnewswire.com
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 9.04%
H: 1.68%
C: -1.49%
covid vaccine approval covid-19
Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia
Published: 2021-10-29 (Crawled : 12:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 1.04%
H: 0.24%
C: -2.2%
covid australia vaccine approval covid-19
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.